AB-FUBINACA

Dosage

Smoked

Oral

Vapourized

TripSit dose text

TripSit's factsheet also states its doses as text.

Vapourized Light: 0.25-0.5mg Common: 0.5-1.5mg Strong: 1.5-3mg Heavy: 3+mg | Oral Light: 0.25-0.5mg Common: 0.5-1.5mg Strong: 1.5-3mg Heavy: 3+mg TS

Duration

TripSit factsheet

Onset

Oral: 30-240 minutes · Vapourized: 1-5 minutes TS

Duration

Oral: 5-15 hours · Vapourized: 1-2 hours TS

Aftereffects

Oral: 2-10 hours · Vapourized: 1-2 hours TS

Mixing

Acute combinations: what happens when these are taken close together. Entries backed by a medical journal or agency are listed first.

Backed by medical journals

PsychonautWiki also lists dangerous combinations shared across a whole group (cannabis) in a table this page does not copy. Read that list on PsychonautWiki.

Risks and toxicity

The toxicity and long-term health effects of recreational AB-FUBINACA use do not seem to have been studied in any scientific context and the exact toxic dosage is unknown. This is because AB-FUBINACA has very little history of human usage. Anecdotal evidence from people who have tried AB-FUBINACA within the community suggest that there do not seem to be any negative health effects attributed to simply trying this drug at low to moderate doses by itself and using it sparingly (but nothing can be completely guaranteed). Informal experiments have shown that overdose will cause physical discomfort including heart palpitations, vertigo and sedation at much lower than dangerous doses, usually causing the user to suffer large amounts of anxiety or to fall asleep. PW

It is worth noting that this compound has been linked to multiple hospitalizations and deaths due to its use.[1][2] PW

It has often been recommended that those with severe pre-existing mental conditions should not ingest these substances due to the way they strongly increase one's current state of mind and emotions. Also, like THC, prolonged usage of synthetic cannabinoids may increase one's disposition to mental illness and psychosis, particularly in vulnerable individuals with risk factors for psychotic illnesses (like a past or family history of schizophrenia).[3–6] PW

As synthetic cannabinoids are active in the milligram range (with below 5mg being a typical dose), it is important to use proper precautions when dosing to avoid a negative experience. PW

It is strongly recommended that one use harm reduction practices when using this drug. PW

Tolerance and addiction potential

As with other synthetic cannabinoids, the chronic use of AB-FUBINACA can be considered moderately addictive with a high potential for abuse and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and withdrawal effects may occur if a person suddenly stops their usage. PW

Tolerance to many of the effects of AB-FUBINACA develops with prolonged and repeated use. This results in users having to administer increasingly large doses to achieve the same effects. After that, it takes about 3 - 7 days for the tolerance to be reduced to half and 1 - 2 weeks to be back at baseline (in the absence of further consumption). AB-FUBINACA presents cross-tolerance with all cannabinoids, meaning that after the consumption of AB-FUBINACA all cannabinoids will have a reduced effect. PW

Testing

User reports